<ѻý>Managing the Safety of Newer Atopic Dermatitis Treatmentsѻý> Our panel of experts discuss how they monitor patients on biologics and JAK inhibitors Dec 01, 2023 video
<ѻý>How and When to Escalate Treatment for Eczemaѻý> Our panel of experts discuss the appropriate time to introduce systemic therapy or switch agents Nov 26, 2023 video
<ѻý>Improving Treatment Adherence in Atopic Dermatitisѻý> We've got great treatments, says Steven Feldman, the key is getting patients to use them Nov 20, 2023
<ѻý>The Landscape of New Treatments for Eczemaѻý> Our panel of experts discuss the "explosion" in new systemic and topical agents Nov 17, 2023 video
<ѻý>Staying Up-to-Date on Approved Therapies in Atopic Dermatitisѻý> James Del Rosso, DO, says to keep an open mind when determining the best option for patients Nov 17, 2023
<ѻý>Year in Review: Atopic Dermatitisѻý> A look back at some of the newsworthy stories of 2023 Nov 01, 2023
<ѻý>Mixed Findings on Link Between Eczema and Neuropsychiatric Conditionsѻý> Increased rates of OCD, anxiety, depression in adults but no clear associations in children Oct 12, 2023
<ѻý>Meta-Analysis Points to Most Effective Topical Treatments for Atopic Dermatitisѻý> Pimecrolimus, tacrolimus, and moderate-potency topical corticosteroids come out on top Sep 08, 2023
<ѻý>Atopic Dermatitis Linked to Increased IBD Risk in Adults and Kidsѻý> Risk increased with severity of atopic dermatitis across both groups, cohort study shows Aug 30, 2023
<ѻý>Pediatric Allergic March Supported by Nationwide EHR Dataѻý> Constellation of comorbid allergic conditions common among children Jul 26, 2023
<ѻý>'Enhanced' Eczema Treatment Cut Food Allergy Risk, but at What Cost?ѻý> Early skin treatment in infants reduced weight and height compared with conventional approach Mar 29, 2023
<ѻý>Asthma, Eczema Tied to Osteoarthritis Riskѻý> Suggests OA is not just about wear and tear Mar 29, 2023
<ѻý>Rapid Improvement in Atopic Dermatitis With Topical PDE4 Inhibitorѻý> Disease status, itch improved significantly within 1 to 2 weeks with roflumilast cream Mar 20, 2023
<ѻý>Childhood Eczema Rose in Past Two Decades, With Unexplained Racial Dividesѻý> Black and multiracial children had the greatest increases in eczema Feb 22, 2023
<ѻý>Dupilumab Delivers in Erythrodermic Atopic Dermatitisѻý> Key clinical outcomes, inflammatory biomarkers significantly reduced with or without steroids Feb 13, 2023
<ѻý>IL-13 Blocker Beats Atopic Dermatitisѻý> With favorable results from three trials, approval seems likely Jan 11, 2023
<ѻý>Inflammation Marker May Spot Atopic Dermatitis Risk Early in Childhoodѻý> Elevated TARC at 2 months more than quadrupled the likelihood of moderate-severe AD at 2 years Sep 06, 2022
<ѻý>Meta-Analysis of Atopic Dermatitis Drugs Favors Two JAK Inhibitorsѻý> Small advantages for abrocitinib, upadacitinib, but data still accumulating for all the players Mar 30, 2022
<ѻý>Atopic Dermatitis: Promising Data for New Mechanistic Approachѻý> Rapid responses in a majority of patients in small trial of eblasakimab Mar 28, 2022
<ѻý>Extension Study Confirms JAK Inhibitor's Activity in Atopic Dermatitisѻý> EASI75 response rate exceeding 80% through 52 weeks of upadacitinib treatment Mar 16, 2022
<ѻý>Evidence Begins to Gel for Atopic Dermatitis, Multiple Comorbid Conditionsѻý> Atopic, metabolic, cardiovascular, and mental health conditions cited in guideline update Feb 02, 2022
<ѻý>FDA OKs Two Oral JAK Inhibitors for Refractory Atopic Dermatitisѻý> Once-daily abrocitinib and upadacitinib join topical ruxolitinib in expanding AD market Jan 18, 2022
<ѻý>Melanoma Patient on Immunotherapy Develops Severe Dermatitisѻý> Clinicians faced with presumed dermatologic AEs urged to consider all differentials Jan 10, 2022
<ѻý>IL-13 Inhibitor Approved for Adults With Atopic Dermatitisѻý> Significantly greater lesion clearance with tralokinumab in placebo-controlled studies Dec 28, 2021
<ѻý>Signs of Relief From 'Therapeutic Drought' in Atopic Dermatitisѻý> Encouraging results from pipeline agents targeting Tѻý-specific inflammation Nov 09, 2021
<ѻý>Early Success With New Target in Atopic Dermatitisѻý> Inhibition of Tѻý-related inflammation leads to rapid improvement in disease activity Nov 05, 2021
<ѻý>FDA Approves First Topical JAK Inhibitor for Atopic Dermatitisѻý> Significant skin clearance, reduced itch in majority of patients treated with ruxolitinib cream Sep 22, 2021
<ѻý>Oral Drug Active in Teens With Atopic Dermatitisѻý> Significant improvement at 12 weeks in 42-46% by one index, 68-72% by another Aug 24, 2021
<ѻý>JAK Inhibitor Tops Mab for Eczemaѻý> New disease-modifying treatment option on the horizon Aug 04, 2021
<ѻý>Rapid Improvement in Atopic Dermatitis With New JAK1 Inhibitorѻý> Plus: First-in-class drug shows promise in AD, BTK inhibitor active in pemphigus May 03, 2021
<ѻý>Rapid Improvement in Atopic Dermatitis With Topical JAK Inhibitorѻý> Disease activity index improved as early as week 1 with delgocitinib cream Apr 27, 2021
<ѻý>Significant Improvement in Hand Eczema With Pan-JAK Inhibitorѻý> Disease activity indicators reduced, no safety signals with gusacitinib versus placebo Apr 26, 2021
<ѻý>Using the Skin Microbiome to Control Atopic Dermatitisѻý> Bacteria-based therapy shows promise in proof-of-concept trial Mar 01, 2021
<ѻý>Young Hidradenitis Suppurativa Patients See Lags in Careѻý> Diagnosis typically came years after disease onset; providers claim lack of knowledge on HS pain Feb 24, 2021
<ѻý>More Evidence for Ligelizumab in Chronic Hivesѻý> Anti-IgE drug showed improved activity in omalizumab-treated patients with inadequate symptom control Nov 17, 2020
<ѻý>Atopic Dermatitis: New Topical Agent, Durable Results With Oralsѻý> Selected abstracts from the European Academy of Dermatology and Venereology Virtual Conference Nov 02, 2020
<ѻý>Calcineurin Blockers for Eczema: No Cancer Signal in Big Studyѻý> "Clinicians can use this evidence to counsel and reassure patients" Aug 12, 2020
<ѻý>Sobering Data on Risks of Short-Term Oral Corticosteroidsѻý> Short steroid bursts linked to serious adverse events within a month Jul 06, 2020
<ѻý>Minimal Link Between Eczema and Most Cancersѻý> Study finds severe eczema tied to small risk for lymphoma Jun 30, 2020
<ѻý>Once-Daily Abrocitinib Succeeds for Atopic Dermatitisѻý> Oral treatment acts as JAK inhibitor Jun 05, 2020